Back

Doxorubicin induces measurable vascular toxicity: assessment in a clinical and preclinical study

30 April 2022 (12:15 - 12:30)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award - Novelties in cardiovascular disease mechanism Biomarkers CBS PREMIUM ACCESS Frontiers in CardioVascular Biomedicine 2022 Council on Basic Cardiovascular Science

About the speaker

Photo
Mr Matthias Bosman

University of Antwerp, Antwerp (Belgium)

3 More presentations in this session

Presentation thumbnail
Modified mRNA delivery to the heart using Lipid Nanoparticles
Ms M. Labonia (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
Intravital & laser speckle investigations of the role of interleukin36 in myocardial ischaemia reperfusion injury; a new therapeutic target for the aged heart
Mr J. El-Awaisi (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
Effective revascularization of non-healing wounds by the human Stromal Vascular Fraction relies on direct cell integration and paracrine signals
Mr R. Vuerich (Frankfurt am Main, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award - Novelties in cardiovascular disease mechanism
Video

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2022

30 April 2022 12:15 CET
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Session
Emerging biomarkers-omics in cardiology: beyond the usual suspects

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources